Publications by authors named "Marina B Felisbino"

Bromodomain and extra-terminal domain (BET) proteins, including BRD4, bind acetylated chromatin and co-activate gene transcription. A BET inhibitor, JQ1, prevents and reverses pathological cardiac remodeling in preclinical models of heart failure. However, the underlying cellular mechanisms by which JQ1 improves cardiac structure and function remain poorly defined.

View Article and Find Full Text PDF
Article Synopsis
  • In vitro cultures of cardiac fibroblasts (CFs) are used to study cardiac fibrosis, but the rigid plastic surfaces lead to unwanted changes in the cells that complicate research outcomes.
  • Using soft PEG hydrogels to mimic the stiffness of healthy and fibrotic hearts, researchers found that low stiffness can revert activated CFs to a quiescent state, although it also increased markers of cellular aging.
  • The study uncovered how CFs adapt their gene expression based on the stiffness of their environment, providing insights into how tissue rigidity influences their behavior and contributes to heart disease.
View Article and Find Full Text PDF
Article Synopsis
  • Organ fibrosis from excessive extracellular matrix production by fibroblasts is a significant contributor to mortality, especially in cardiovascular diseases, prompting research into small molecule inhibitors that can suppress fibroblast activation.
  • High-content imaging was employed to test various compounds for their ability to block fibroblast activation markers, identifying SW033291 as a promising candidate that inhibits a specific enzyme involved in eicosanoid degradation.
  • SW033291 effectively reduced activation markers in both rat and human cardiac fibroblasts, reversed activation in fibroblasts from heart failure patients, and improved cardiac fibrosis and diastolic dysfunction in mouse models, signaling its potential as a therapeutic agent.
View Article and Find Full Text PDF

Because the liver plays a major role in metabolic homeostasis and secretion of clotting factors and inflammatory innate immune proteins, there is interest in understanding the mechanisms of hepatic cell activation under hyperglycaemia and whether this can be attenuated pharmacologically. We have previously shown that hyperglycaemia stimulates major changes in chromatin organization and metabolism in hepatocytes, and that the histone deacetylase inhibitor valproic acid (VPA) is able to reverse some of these metabolic changes. In this study, we have used RNA-sequencing (RNA-seq) to investigate how VPA influences gene expression in hepatocytes.

View Article and Find Full Text PDF

Sodium valproate/valproic acid (VPA), a histone deacetylase inhibitor, and 5-aza-2-deoxycytidine (5-aza-CdR), a DNA methyltransferase 1 (DNMT1) inhibitor, induce DNA demethylation in several cell types. In HeLa cells, although VPA leads to decreased DNA 5-methylcytosine (5mC) levels, the demethylation pathway involved in this effect is not fully understood. We investigated this process using flow cytometry, ELISA, immunocytochemistry, Western blotting and RT-qPCR in G1 phase-arrested and proliferative HeLa cells compared to the presumably passive demethylation promoted by 5-aza-CdR.

View Article and Find Full Text PDF
Article Synopsis
  • BRD4 is identified as a key regulator in cardiac fibrosis, particularly through its role in TGF-β signaling that activates cardiac fibroblasts, the main cells involved in producing heart tissue's extracellular matrix.
  • Using techniques like RNA-sequencing and mass spectrometry, researchers showed that BRD4 can change the behavior of cardiac fibroblasts, prompting them to produce more extracellular matrix proteins in response to heart stress.
  • The study highlights that BRD4's activity is influenced by specific signals, causing it to relocate within the genome and interact with certain genes, suggesting targeted approaches for treating heart failure-associated fibrosis could be developed.
View Article and Find Full Text PDF

Chemical modifications to nucleosomal DNA and histone tails greatly influence transcription of adjacent and distant genes, a mode of gene regulation referred to as epigenetic control. Here, the authors summarize recent findings that have illustrated crucial roles for epigenetic regulatory enzymes and reader proteins in the control of cardiac fibrosis. Particular emphasis is placed on epigenetic regulation of stress-induced inflammation and fibroblast activation in the heart.

View Article and Find Full Text PDF

Valproic acid (VPA), a well-known histone deacetylase inhibitor, has been reported to affect the DNA methylation status in addition to inducing histone hyperacetylation in several cell types. In HeLa cells, VPA promotes histone acetylation and chromatin remodeling. However, DNA demethylation was not checked in this cell model for standing effects longer than those provided by histone acetylation, which is a rapid and transient phenomenon.

View Article and Find Full Text PDF

Triatoma infestans, a vector of Chagas' disease, shows several particular cell biology characteristics, including the presence of conspicuous heterochromatic bodies (chromocenters) where DNA methylation has not been previously detected. Whether histone modifications contribute to the condensed state of these bodies has not yet been studied. Here, we investigated epigenetic modifications of histones H3 and H4 and presence of the non-histone heterochromatin protein (HP1-α) in the chromocenters and euchromatin of T.

View Article and Find Full Text PDF

Diabetes is a complex multifactorial disorder characterized by chronic hyperglycemia due to impaired insulin secretion. Recent observations suggest that the complexity of the disease cannot be entirely accounted for genetic predisposition and a compelling argument for an epigenetic component is rapidly emerging. The use of histone deacetylase inhibitor (HDACi) in clinical setting is an emerging area of investigation.

View Article and Find Full Text PDF

Valproic acid (VPA) and trichostatin A (TSA) are known histone deacetylase inhibitors (HDACIs) with epigenetic activity that affect chromatin supra-organization, nuclear architecture, and cellular proliferation, particularly in tumor cells. In this study, chromatin remodeling with effects extending to heterochromatic areas was investigated by image analysis in non-transformed NIH 3T3 cells treated for different periods with different doses of VPA and TSA under conditions that indicated no loss of cell viability. Image analysis revealed chromatin decondensation that affected not only euchromatin but also heterochromatin, concomitant with a decreased activity of histone deacetylases and a general increase in histone H3 acetylation.

View Article and Find Full Text PDF

Chromatin packaging plays a significant role in regulating gene transcription. Study of the higher-order packing states of chromatin by image analysis at the light microscope level, especially when validated by methods of molecular biology, immunochemistry, and/or immunocytochemistry, enabled the detection of changes involved in the processes associated with or preceding alterations in transcriptional activities. Here, we recommend and describe the use of relatively simple methods for staining and detecting chromatin remodelling by image analysis.

View Article and Find Full Text PDF

Background: Valproic acid (VPA) is a potent anticonvulsant that inhibits histone deacetylases. Because of this inhibitory action, we investigated whether VPA would affect chromatin supraorganization, mitotic indices and the frequency of chromosome abnormalities and cell death in HeLa cells.

Methodology/principal Findings: Image analysis was performed by scanning microspectrophotometry for cells cultivated for 24 h, treated with 0.

View Article and Find Full Text PDF